Lazabemide for the treatment of Alzheimer's disease: rationale and therapeutic perspectives

Adv Neurol. 1999:80:521-8.
No abstract available

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Animals
  • Brain / enzymology
  • Humans
  • Mice
  • Mice, Transgenic / metabolism
  • Monoamine Oxidase / drug effects
  • Monoamine Oxidase / metabolism
  • Monoamine Oxidase Inhibitors / therapeutic use*
  • Neurodegenerative Diseases / physiopathology
  • Oxidative Stress / physiology
  • Picolinic Acids / therapeutic use*

Substances

  • Monoamine Oxidase Inhibitors
  • Picolinic Acids
  • lazabemide
  • Monoamine Oxidase